HeartFlow, Inc. (HTFL)
| Market Cap | 2.38B |
| Revenue (ttm) | 161.88M |
| Net Income (ttm) | -125.37M |
| Shares Out | 85.16M |
| EPS (ttm) | -7.38 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 844,373 |
| Open | 29.79 |
| Previous Close | 29.62 |
| Day's Range | 27.80 - 30.36 |
| 52-Week Range | 25.75 - 41.22 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 39.50 (+41.07%) |
| Earnings Date | Nov 12, 2025 |
About HTFL
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient’s heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart’s arteries. The company’s platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for HTFL stock is "Strong Buy." The 12-month stock price target is $39.5, which is an increase of 41.07% from the latest price.
News
Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO
Tulsa-based Schusterman Interests added 1,939,201 shares of HeartFlow valued at $65.3 million in the third quarter. The position represents 14.9% of the fund's 13F reportable assets under management.
Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million
Added 12,448,158 shares in a new position, increasing reported holdings by $419.00 million Post-trade, the fund holds 12,448,158 shares worth $419.00 million The position now represents 27.81% of fund...
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today anno...
Where Innovation Meets the Heart: Stanford's New Position in HeartFlow
Acquired 312,234 shares of HeartFlow, estimated at ~$10.51 million based on quarterly average price Post-trade position: 312,234 shares, valued at $10.51 million as of 2025-09-30 New position places H...
Heartflow Reports Third Quarter 2025 Financial Results
MOUNTAIN VIEW, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today repo...
Baron Technology Fund: AI Update
The market has recently absorbed a surge of activity around AI infrastructure buildouts. NVIDIA CEO Jensen Huang proclaimed in September that global AI infrastructure spending could total $3 trillion ...
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
NEW ORLEANS, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced late-breaking data from the FI...
Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025
MOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new ...
Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025
MOUNTAIN VIEW, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release fina...
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning
PLAN CALCIUM study to be presented at TCT 2025 conference highlights how AI-powered plaque analysis can inform lesion preparation and calcium modification planning NAVIGATE-PCI registry to enroll appr...
Why HeartFlow Stock Rocketed 14% Higher Today
Just after market close on Tuesday, specialized medical device company HeartFlow (HTFL 14.13%) was the very picture of health, as far as its stock was concerned. The company's shares saw a robust 14% ...
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide
Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of mana...
Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its ups...
HeartFlow: Investors Put Their Heart In
HeartFlow's AI-driven, non-invasive CAD diagnostic platform addresses a large, growing market with significant clinical need and strong early adoption. The IPO valued HeartFlow at $1.5 billion, equal ...
Heartflow Stock Opens Nearly 50% Above IPO Price in Latest Hot Debut
Medical imaging company Heartflow rose nearly 50% on its first day, joining Firefly, Figma, and Circle as big IPO gainers.
Medtech firm Heartflow gains 47% in solid Nasdaq debut
Shares of Heartflow rose nearly 47.4% in their Nasdaq debut on Friday, valuing the medical technology company at $2.27 billion.
Medtech firm Heartflow raises $316.7 million in US IPO
Medical technology firm Heartflow said on Thursday it has raised $316.7 million in its U.S. initial public offering.
Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering
MOUNTAIN VIEW, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the pricing of its ups...
Bain Capital-backed Heartflow targets $1.5 billion valuation in upsized US IPO
Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized initial public offering in the United States, indicating robust investor deman...
Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation
It seems there's fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, investors might have another chance to get their heart rates up again soon.
Bain Capital-backed Heartflow eyes $1.3 billion valuation in US IPO
Healthcare firm Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its initial public offering in the United States.
Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide
Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients Largest commer...
Heartflow Pursues IPO On Growing Revenue And High Operating Losses
Heartflow has filed to raise $100 million in a US IPO, although the final amount may differ. IPO proceeds will primarily pay down debt and fund R&D, sales, and product development, aiming to extend ru...
Coronary AI diagnostic developer Heartflow files $100M IPO
Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO.